Metastatic hepatic (liver) cancer occurs when cancer that originated from another organ spreads and infects the liver. It is also commonly known as secondary liver cancer as the cancer did not begin in the liver. The liver is a common place for this to occur as its large size as well as high blood flow makes it especially vulnerable to infection by way of cancer cells moving through the blood stream. Metastatic hepatic cancer is most commonly caused by colorectal, breast, and lung cancer. Treatments for liver metastases include surgery, chemotherapy, radiation therapy, biologic therapies, and image-guided therapies.
Top Research Reagents
We have 6144 products for the study of Hepatic Cancer Metastatic that can be applied to Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.